{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T19:56:13Z","timestamp":1758052573909,"version":"3.44.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004569","name":"Ministerstwo Nauki i Szkolnictwa Wy\u017cszego","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.cbi.2013.07.011","type":"journal-article","created":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T22:02:17Z","timestamp":1375394537000},"page":"198-211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Characterization of arsenic trioxide resistant clones derived from Jurkat leukemia T cell line: Focus on PI3K\/Akt signaling pathway"],"prefix":"10.1016","volume":"205","author":[{"given":"Joanna","family":"Roszak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Smok-Pieni\u0105\u017cek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Nocu\u0144","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej","family":"St\u0119pnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2013.07.011_b0005","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJM199811053391901","article-title":"Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide","volume":"339","author":"Soignet","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2013.07.011_b0010","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/shem.2002.33611","article-title":"Expanding the use of arsenic trioxide: leukemias and beyond","volume":"39","author":"Chen","year":"2002","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.cbi.2013.07.011_b0015","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/BF02983237","article-title":"Treatment of acute promyelocytic leukemia and other hematologic malignancies with arsenic trioxide: review of clinical and basic studies","volume":"78","author":"Liu","year":"2003","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.cbi.2013.07.011_b0020","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1365-2141.2005.05679.x","article-title":"Phosphoinositide 3-kinase\/Akt inhibition increases arsenic trioxide-induced apoptosis of acute promyelocytic and T-cell leukaemias","volume":"130","author":"Tabellini","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.cbi.2013.07.011_b0025","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.leukres.2004.01.011","article-title":"The potential of arsenic trioxide in the treatment of malignant disease: past, present, and future","volume":"28","author":"Evens","year":"2004","journal-title":"Leuk. Res."},{"key":"10.1016\/j.cbi.2013.07.011_b0030","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1080\/10428190412331272686","article-title":"Arsenic trioxide therapy in acute promyelocytic leukemia and beyond: from bench to bedside","volume":"45","author":"Rojewski","year":"2004","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.cbi.2013.07.011_b0035","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1200\/JCO.2005.10.217","article-title":"Arsenic trioxide: new clinical experience with an old medication in hematologic malignancies","volume":"23","author":"Douer","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cbi.2013.07.011_b0040","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0092-8674(00)80405-5","article-title":"Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery","volume":"91","author":"Datta","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2013.07.011_b0045","doi-asserted-by":"crossref","first-page":"19929","DOI":"10.1074\/jbc.273.32.19929","article-title":"Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase\/Akt cell survival pathway","volume":"273","author":"Pap","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2013.07.011_b0050","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.282.5392.1318","article-title":"Regulation of cell death protease caspase-9 by phosphorylation","volume":"282","author":"Cardone","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.cbi.2013.07.011_b0055","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0960-9822(99)80265-6","article-title":"Induction of NF-kappaB by the Akt\/PKB kinase","volume":"9","author":"Kane","year":"1999","journal-title":"Curr. Biol."},{"key":"10.1016\/j.cbi.2013.07.011_b0060","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0092-8674(00)80595-4","article-title":"Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor","volume":"96","author":"Brunet","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2013.07.011_b0065","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0898-6568(01)00271-6","article-title":"The protein kinase B\/Akt signalling pathway in human malignancy","volume":"14","author":"Nicholson","year":"2002","journal-title":"Cell. Signal."},{"key":"10.1016\/j.cbi.2013.07.011_b0070","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1182\/blood.V96.10.3560","article-title":"Loss of PTEN expression leading to high Akt activation in human multiple myelomas","volume":"96","author":"Hyun","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cbi.2013.07.011_b0075","first-page":"851","article-title":"Arsenic trioxide inhibits growth of human multiple myeloma cells in the bone marrow microenvironment","volume":"1","author":"Hayashi","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.cbi.2013.07.011_b0080","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1182\/blood-2006-12-060970","article-title":"Low-dose arsenic trioxide sensitizes glucocorticoid-resistant acute lymphoblastic leukemia cells to dexamethasone via an Akt-dependent pathway","volume":"110","author":"Bornhauser","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cbi.2013.07.011_b0085","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1046\/j.1365-2141.1998.00869.x","article-title":"Arsenic induces apoptosis in B-cell leukaemic cell lines in vitro: activation of caspases and down-regulation of Bcl-2 protein","volume":"102","author":"Akao","year":"1998","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.cbi.2013.07.011_b0090","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1182\/blood.V88.3.1052.1052","article-title":"In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML\u2013RAR alpha\/PML proteins","volume":"88","author":"Chen","year":"1996","journal-title":"Blood"},{"issue":"Suppl. 1","key":"10.1016\/j.cbi.2013.07.011_b0095","doi-asserted-by":"crossref","first-page":"11842","DOI":"10.1073\/pnas.2034201100","article-title":"Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?","volume":"100","author":"Passegu\u00e9","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cbi.2013.07.011_b0100","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrc2499","article-title":"Cancer stem cells in solid tumours: accumulating evidence and unresolved questions","volume":"8","author":"Visvader","year":"2008","journal-title":"Nature Rev Cancer"},{"key":"10.1016\/j.cbi.2013.07.011_b0105","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.toxlet.2013.03.019","article-title":"Arsenic trioxide depletes cancer stem-like cells and inhibits repopulation of neurosphere derived from glioblastoma by downregulation of Notch pathway","volume":"220","author":"Wu","year":"2013","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.cbi.2013.07.011_b0110","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.canlet.2009.11.005","article-title":"Arsenic trioxide-mediated Notch pathway inhibition depletes the cancer stem-like cell population in gliomas","volume":"292","author":"Zhen","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cbi.2013.07.011_b0115","first-page":"758","article-title":"Arsenic trioxide sensitizes cancer stem cells to chemoradiotherapy. A new approach in the treatment of inoperable glioblastoma multiforme","volume":"15","author":"Tomuleasa","year":"2010","journal-title":"J. BUON"},{"key":"10.1016\/j.cbi.2013.07.011_b0120","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/sj.leu.2403585","article-title":"Arsenic trioxide (ATO) and MEK1 inhibition synergize to induce apoptosis in acute promyelocytic leukemia cells","volume":"19","author":"Lunghi","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.cbi.2013.07.011_b0125","doi-asserted-by":"crossref","first-page":"15600","DOI":"10.1074\/jbc.M111142200","article-title":"Insulin-like growth factor I induces MDM2-dependent degradation of p53 via the p38 MAPK pathway in response to DNA damage","volume":"277","author":"H\u00e9ron-Milhavet","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2013.07.011_b0130","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1006\/bbrc.1993.2438","article-title":"A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5\u2032,6,6\u2032-tetrachloro-1,1\u2032,3,3\u2032-tetraethylbenzimidazolcarbocyanine iodide (JC-1)","volume":"197","author":"Cossarizza","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2013.07.011_b0135","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol."},{"key":"10.1016\/j.cbi.2013.07.011_b0140","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.bbrc.2004.06.038","article-title":"Inhibition of phosphatidylinositol 3\u2019-kinase induces preferentially killing of PTEN-null T leukemias through AKT pathway","volume":"320","author":"Uddin","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2013.07.011_b0145","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrc1819","article-title":"Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis","volume":"6","author":"Cully","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cbi.2013.07.011_b0150","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1182\/blood-2006-04-016907","article-title":"Role of phosphatidylinositol 3\u2032-kinase\/AKT pathway in diffuse large B-cell lymphoma survival","volume":"108","author":"Uddin","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cbi.2013.07.011_b0155","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.1128\/MCB.20.18.6945-6957.2000","article-title":"Deficiency of PTEN in Jurkat T cells causes constitutive localization of Itk to the plasma membrane and hyperresponsiveness to CD3 stimulation","volume":"20","author":"Shan","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cbi.2013.07.011_b0160","first-page":"603","article-title":"Arsenic trioxide-induced apoptosis in U937 cells involve generation of reactive oxygen species and inhibition of Akt","volume":"21","author":"Choi","year":"2002","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.cbi.2013.07.011_b0165","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.3748\/wjg.v18.i45.6537","article-title":"Anti-tumor immunity, autophagy and chemotherapy","volume":"18","author":"M\u0171zes","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cbi.2013.07.011_b0170","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/jnci\/djq093","article-title":"Arsenic-specific stem cell selection during malignant transformation","volume":"102","author":"Tokar","year":"2010","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.cbi.2013.07.011_b0175","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1158\/1078-0432.CCR-10-0072","article-title":"Induction of B-chronic lymphocytic leukemia cell apoptosis by arsenic trioxide involves suppression of the phosphoinositide 3-kinase\/Akt survival pathway via c-jun-NH2 terminal kinase activation and PTEN upregulation","volume":"16","author":"Redondo-Mu\u00f1oz","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cbi.2013.07.011_b0180","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/emboj\/16.7.1695","article-title":"Induction of apoptosis by the transcription factor c-Jun","volume":"16","author":"Bossy-Wetzel","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.cbi.2013.07.011_b0185","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.1038\/sj.onc.1203173","article-title":"Diverse functions of JNK signaling and c-Jun in stress response and apoptosis","volume":"18","author":"Lepp\u00e4","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.cbi.2013.07.011_b0190","doi-asserted-by":"crossref","first-page":"28546","DOI":"10.1074\/jbc.M102075200","article-title":"Protective role for c-Jun in the cellular response to DNA damage","volume":"276","author":"Potapova","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2013.07.011_b0195","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/emboj\/18.1.188","article-title":"C-Jun regulates cell cycle progression and apoptosis by distinct mechanisms","volume":"18","author":"Wisdom","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.cbi.2013.07.011_b0200","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0092-8674(95)90411-5","article-title":"Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death","volume":"80","author":"Yang","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2013.07.011_b0205","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1038\/cddis.2012.89","article-title":"Glucocorticoid-mediated BIM induction and apoptosis are regulated by Runx2 and c-Jun in leukemia cells","volume":"3","author":"Heidari","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cbi.2013.07.011_b0210","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0962-8924(96)20025-X","article-title":"ICE\/CED-3 proteases in apoptosis","volume":"6","author":"Whyte","year":"1996","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.cbi.2013.07.011_b0215","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1126\/science.7535475","article-title":"Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme","volume":"267","author":"Kuida","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.cbi.2013.07.011_b0220","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0092-8674(00)81265-9","article-title":"Involvement of MACH, a novel MORT1\/FADD-interacting protease, in Fas\/APO-1- and TNF receptor-induced cell death","volume":"85","author":"Boldin","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2013.07.011_b0225","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0962-8924(96)30061-5","article-title":"A link between cell-surface receptors and ICE proteases","volume":"6","author":"Whyte","year":"1996","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.cbi.2013.07.011_b0230","doi-asserted-by":"crossref","first-page":"31791","DOI":"10.1074\/jbc.271.50.31791","article-title":"Type I insulin-like growth factor receptor activation regulates apoptotic proteins","volume":"271","author":"Singleton","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2013.07.011_b0235","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1749-6632.1995.tb26689.x","article-title":"The role of the insulin-like growth factor-I receptor in cancer","volume":"766","author":"LeRoith","year":"1995","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.cbi.2013.07.011_b0240","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1210\/edrv.21.3.0399","article-title":"The effects of insulin-like growth factors on tumorigenesis and neoplastic growth","volume":"21","author":"Khandwala","year":"2000","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.cbi.2013.07.011_b0245","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1002\/cncr.10945","article-title":"Overexpression of the insulin-like growth factor I receptor in human colon carcinomas","volume":"95","author":"Weber","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.cbi.2013.07.011_b0250","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0014-5793(01)02282-7","article-title":"The BPS domain of Grb10 inhibits the catalytic activity of the insulin and IGF1 receptors","volume":"493","author":"Stein","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cbi.2013.07.011_b0255","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/jcp.10363","article-title":"Grb10 adapter protein as regulator of insulin-like growth factor receptor signaling","volume":"197","author":"Morrione","year":"2003","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.cbi.2013.07.011_b0260","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1210\/en.2005-0150","article-title":"The adapter protein GRB10 is an endogenous negative regulator of insulin-like growth factor signaling","volume":"146","author":"Dufresne","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.cbi.2013.07.011_b0265","doi-asserted-by":"crossref","first-page":"6860","DOI":"10.1074\/jbc.273.12.6860","volume":"273","author":"He","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2013.07.011_b0270","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1128\/MCB.22.4.979-991.2002","article-title":"Role for the adaptor protein Grb10 in the activation of Akt","volume":"22","author":"Jahn","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cbi.2013.07.011_b0275","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.1038\/sj.onc.1203958","article-title":"Signaling network of the Btk family kinases","volume":"19","author":"Qiu","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.cbi.2013.07.011_b0280","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1073\/pnas.94.8.3938","article-title":"Bruton\u2019s tyrosine kinase regulates apoptosis and JNK\/SAPK kinase activity","volume":"94","author":"Kawakami","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cbi.2013.07.011_b0285","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0006-2952(98)00122-1","article-title":"Bruton\u2019s tyrosine kinase (BTK) as a dual-function regulator of apoptosis","volume":"56","author":"Uckun","year":"1998","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2013.07.011_b0290","doi-asserted-by":"crossref","first-page":"6564","DOI":"10.1038\/sj.onc.1203065","article-title":"Protein kinase C-alpha overexpression stimulates Akt activity and suppresses apoptosis induced by interleukin 3 withdrawal","volume":"18","author":"Li","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.cbi.2013.07.011_b0295","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1084\/jem.192.5.729","article-title":"Akt-dependent cytokine production in mast cells","volume":"192","author":"Kitaura","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cbi.2013.07.011_b0300","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1084\/jem.191.10.1745","article-title":"Bruton\u2019s tyrosine kinase is required for activation of IkappaB kinase and nuclear factor kappaB in response to B cell receptor engagement","volume":"191","author":"Petro","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cbi.2013.07.011_b0305","doi-asserted-by":"crossref","first-page":"7118","DOI":"10.1073\/pnas.130198197","article-title":"Regulation of oxidative stress-induced calcium release by phosphatidylinositol 3-kinase and Bruton\u2019s tyrosine kinase in B cells","volume":"97","author":"Qin","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cbi.2013.07.011_b0310","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00204-012-0856-9","article-title":"NADPH oxidase-produced superoxide mediates EGFR transactivation by c-Src in arsenic trioxide-stimulated human keratinocytes","volume":"86","author":"Tseng","year":"2012","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.cbi.2013.07.011_b0315","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1046\/j.1365-2567.2002.01525.x","article-title":"Insulin-like growth factor-1 activates Akt and Jun N-terminal kinases (JNKs) in promoting the survival of T lymphocytes","volume":"107","author":"Walsh","year":"2002","journal-title":"Immunology"},{"key":"10.1016\/j.cbi.2013.07.011_b0320","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1476-4598-6-24","article-title":"The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention","volume":"6","author":"Alao","year":"2007","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cbi.2013.07.011_b0325","doi-asserted-by":"crossref","first-page":"32649","DOI":"10.1074\/jbc.M000643200","article-title":"The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3beta and cAMP-responsive element-binding protein-dependent pathways","volume":"275","author":"D\u2019Amico","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2013.07.011_b0330","doi-asserted-by":"crossref","first-page":"27907","DOI":"10.1074\/jbc.M104278200","article-title":"Forkhead homologue in rhabdomyosarcoma functions as a bifunctional nuclear receptor-interacting protein with both coactivator and corepressor functions","volume":"276","author":"Zhao","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2013.07.011_b0335","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1189\/jlb.1202629","article-title":"Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB\/Akt is off duty","volume":"73","author":"Burgering","year":"2003","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cbi.2013.07.011_b0340","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1089\/ars.2010.3403","article-title":"Forkhead box o as a sensor, mediator, and regulator of redox signaling","volume":"14","author":"de Keizer","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.cbi.2013.07.011_b0345","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1089\/ars.2010.3415","article-title":"Integrating opposing signals toward Forkhead box O","volume":"14","author":"van den Berg","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.cbi.2013.07.011_b0350","doi-asserted-by":"crossref","first-page":"7842","DOI":"10.1128\/MCB.22.22.7842-7852.2002","article-title":"Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D","volume":"22","author":"Schmidt","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cbi.2013.07.011_b0355","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000332337","article-title":"Inhibition of protein kinase C \u03b2(2) prevents tumor necrosis factor-\u03b1-induced apoptosis and oxidative stress in endothelial cells: the role of NADPH oxidase subunits","volume":"49","author":"Deng","year":"2012","journal-title":"J. Vasc. Res."},{"key":"10.1016\/j.cbi.2013.07.011_b0360","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1002\/j.1460-2075.1994.tb06578.x","article-title":"Zeta PKC induces phosphorylation and inactivation of I kappa B-alpha in vitro","volume":"13","author":"Diaz-Meco","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/j.cbi.2013.07.011_b0365","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1128\/MCB.19.4.2921","article-title":"P70 S6 kinase is regulated by protein kinase Czeta and participates in a phosphoinositide 3-kinase-regulated signalling complex","volume":"19","author":"Romanelli","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cbi.2013.07.011_b0370","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.semcdb.2003.12.022","article-title":"PDK1, the master regulator of AGC kinase signal transduction","volume":"15","author":"Mora","year":"2004","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.cbi.2013.07.011_b0375","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1038\/sj.emboj.7601166","article-title":"The mTOR\/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity","volume":"25","author":"Shahbazian","year":"2006","journal-title":"EMBO J."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279713001816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279713001816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:29:45Z","timestamp":1757856585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279713001816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0009279713001816"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2013.07.011","relation":{},"ISSN":["0009-2797"],"issn-type":[{"type":"print","value":"0009-2797"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of arsenic trioxide resistant clones derived from Jurkat leukemia T cell line: Focus on PI3K\/Akt signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2013.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}